Mario M. Leitao, Jr, MD, FACOG, FACS, program director of Gynecologic Oncology at Memorial Sloan Kettering Cancer Center, discusses what is currently being investigated in the treatment landscape of ovarian cancers.
Videos
Amanda Ramos, MD, a first-year fellow at the Massachusetts General Hospital in Boston, discusses the future potential of checkpoint inhibition therapy in the treatment of patients with recurrent endometrial cancers.
Frontline Treatment Strategies in EGFR-Mutant NSCLC
Scott Kopetz, MD, associate professor of GI Medical Oncology at MD Anderson Center, advises community oncologists on what testing should be done for patients with colorectal cancer.
Therapeutic Management of Immune Thrombocytopenia
Therapeutic Management of Immune Thrombocytopenia
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Phase 3 Data Highlight Orca-T’s Clinical Benefits in Heme Malignancies
2
Targeting HER2-Low Breast Cancer: the ARX788 Phase 2 Clinical Trial
3
Response Rates with Pumitamig Plus Chemo Suggest Synergistic Effect
4
Early Relapse Guides Use of CAR T vs Other Options in LBCL
5